ArticleAnnals of cardiothoracic surgery2025
Are frozen elephant trunks freezing out conventional ones? A systematic review and meta-analysis.
Article in Annals of cardiothoracic surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The frozen elephant trunk (fET) has become the preeminent choice for aortic arch repair with easier second-stage endovascular solutions compared to the conventional elephant trunk (cET). Traditionally, the major advantage of cET implantation is reduced risk of spinal cord injury (SCI). With increased rates of implantation and refinement in technique, we aim to investigate if previous adverse events of fET, such as SCI, have been reduced to a level comparable to the cET. Methods: Four databases were searched from inception to January 2025. All studies reporting 30-day mortality and SCI in conventional or fETs were identified. Papers that included emergency surgery in a mixed cohort or novel and handmade prosthesis were excluded. Relevant data was extracted, and meta-analysis was conducted using a random effects model. Results: Twenty-eight studies were included with a total of 1,504 patients (122 cET, 1,382 fET). Cohort sizes ranged from 12 to 126 patients. The aggregate mean age was 60.7 years for fET and 65.6 years for cET. The 30-day mortality was 5.4% for fET and 3.9% for cET. There was a signal towards increased SCI for fET at 4.4% compared to 1.2% in cET. Conclusions: In non-emergent total arch replacement, there were similar rates of 30-day mortality. There was a signal towards increased SCI for fETs compared to cETs. Meta-regression identified a non-significant trend towards decreasing rates of SCI in fETs over time.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.